List of Tables
    Table 1. β2 Adrenoceptor Agonists Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. β2 Adrenoceptor Agonists Market Trends
    Table 3. β2 Adrenoceptor Agonists Market Drivers
    Table 4. β2 Adrenoceptor Agonists Market Challenges
    Table 5. β2 Adrenoceptor Agonists Market Restraints
    Table 6. Global β2 Adrenoceptor Agonists Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States β2 Adrenoceptor Agonists Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global β2 Adrenoceptor Agonists Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States β2 Adrenoceptor Agonists Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top β2 Adrenoceptor Agonists Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global β2 Adrenoceptor Agonists Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global β2 Adrenoceptor Agonists Revenue Share by Player, 2017-2022
    Table 13. Global β2 Adrenoceptor Agonists Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global β2 Adrenoceptor Agonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in β2 Adrenoceptor Agonists as of 2021)
    Table 15. Top Players of β2 Adrenoceptor Agonists in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in β2 Adrenoceptor Agonists Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into β2 Adrenoceptor Agonists Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top β2 Adrenoceptor Agonists Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States β2 Adrenoceptor Agonists Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States β2 Adrenoceptor Agonists Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global β2 Adrenoceptor Agonists Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global β2 Adrenoceptor Agonists Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global β2 Adrenoceptor Agonists Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America β2 Adrenoceptor Agonists Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific β2 Adrenoceptor Agonists Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe β2 Adrenoceptor Agonists Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa β2 Adrenoceptor Agonists Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa β2 Adrenoceptor Agonists Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Ivax Pharmaceuticals  Company Details
    Table 31. Ivax Pharmaceuticals  Business Overview
    Table 32. Ivax Pharmaceuticals  β2 Adrenoceptor Agonists Product
    Table 33. Ivax Pharmaceuticals  Revenue in β2 Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 34. Ivax Pharmaceuticals  Recent Development
    Table 35. Physicians Total Care Company Details
    Table 36. Physicians Total Care Business Overview
    Table 37. Physicians Total Care β2 Adrenoceptor Agonists Product
    Table 38. Physicians Total Care Revenue in β2 Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 39. Physicians Total Care Recent Development
    Table 40. Baxter Healthcare  Company Details
    Table 41. Baxter Healthcare  Business Overview
    Table 42. Baxter Healthcare  β2 Adrenoceptor Agonists Product
    Table 43. Baxter Healthcare  Revenue in β2 Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 44. Baxter Healthcare  Recent Development
    Table 45. Sanofi Company Details
    Table 46. Sanofi Business Overview
    Table 47. Sanofi β2 Adrenoceptor Agonists Product
    Table 48. Sanofi Revenue in β2 Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 49. Sanofi Recent Development
    Table 50. Pfizer Company Details
    Table 51. Pfizer Business Overview
    Table 52. Pfizer β2 Adrenoceptor Agonists Product
    Table 53. Pfizer Revenue in β2 Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 54. Pfizer Recent Development
    Table 55. Bedford Laboratories Company Details
    Table 56. Bedford Laboratories Business Overview
    Table 57. Bedford Laboratories β2 Adrenoceptor Agonists Product
    Table 58. Bedford Laboratories Revenue in β2 Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 59. Bedford Laboratories Recent Development
    Table 60. Novartis Company Details
    Table 61. Novartis Business Overview
    Table 62. Novartis β2 Adrenoceptor Agonists Product
    Table 63. Novartis Revenue in β2 Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 64. Novartis Recent Development
    Table 65. Sterimax Company Details
    Table 66. Sterimax Business Overview
    Table 67. Sterimax β2 Adrenoceptor Agonists Product
    Table 68. Sterimax Revenue in β2 Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 69. Sterimax Recent Development
    Table 70. Teligent Company Details
    Table 71. Teligent Business Overview
    Table 72. Teligent β2 Adrenoceptor Agonists Product
    Table 73. Teligent Revenue in β2 Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 74. Teligent Recent Development
    Table 75. AstraZeneca Company Details
    Table 76. AstraZeneca Business Overview
    Table 77. AstraZeneca β2 Adrenoceptor Agonists Product
    Table 78. AstraZeneca Revenue in β2 Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 79. AstraZeneca Recent Development
    Table 80. Hikma Pharmaceuticals Company Details
    Table 81. Hikma Pharmaceuticals Business Overview
    Table 82. Hikma Pharmaceuticals β2 Adrenoceptor Agonists Product
    Table 83. Hikma Pharmaceuticals Revenue in β2 Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 84. Hikma Pharmaceuticals Recent Development
    Table 85. Av Kare Company Details
    Table 86. Av Kare Business Overview
    Table 87. Av Kare β2 Adrenoceptor Agonists Product
    Table 88. Av Kare Revenue in β2 Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 89. Av Kare Recent Development
    Table 90. Impax Laboratories Company Details
    Table 91. Impax Laboratories Business Overview
    Table 92. Impax Laboratories β2 Adrenoceptor Agonists Product
    Table 93. Impax Laboratories Revenue in β2 Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 94. Impax Laboratories Recent Development
    Table 95. PD-Rx Pharmaceuticals Company Details
    Table 96. PD-Rx Pharmaceuticals Business Overview
    Table 97. PD-Rx Pharmaceuticals β2 Adrenoceptor Agonists Product
    Table 98. PD-Rx Pharmaceuticals Revenue in β2 Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 99. PD-Rx Pharmaceuticals Recent Development
    Table 100. Athenex Pharmaceutical Division Company Details
    Table 101. Athenex Pharmaceutical Division Business Overview
    Table 102. Athenex Pharmaceutical Division β2 Adrenoceptor Agonists Product
    Table 103. Athenex Pharmaceutical Division Revenue in β2 Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 104. Athenex Pharmaceutical Division Recent Development
    Table 105. Teva Company Details
    Table 106. Teva Business Overview
    Table 107. Teva β2 Adrenoceptor Agonists Product
    Table 108. Teva Revenue in β2 Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 109. Teva Recent Development
    Table 110. Marlex Pharmaceuticals Company Details
    Table 111. Marlex Pharmaceuticals Business Overview
    Table 112. Marlex Pharmaceuticals β2 Adrenoceptor Agonists Product
    Table 113. Marlex Pharmaceuticals Revenue in β2 Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 114. Marlex Pharmaceuticals Recent Development
    Table 115. Lannett Company Company Details
    Table 116. Lannett Company Business Overview
    Table 117. Lannett Company β2 Adrenoceptor Agonists Product
    Table 118. Lannett Company Revenue in β2 Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 119. Lannett Company Recent Development
    Table 120. West-Ward Pharmaceuticals Company Details
    Table 121. West-Ward Pharmaceuticals Business Overview
    Table 122. West-Ward Pharmaceuticals β2 Adrenoceptor Agonists Product
    Table 123. West-Ward Pharmaceuticals Revenue in β2 Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 124. West-Ward Pharmaceuticals Recent Development
    Table 125. United Biomedical Company Details
    Table 126. United Biomedical Business Overview
    Table 127. United Biomedical β2 Adrenoceptor Agonists Product
    Table 128. United Biomedical Revenue in β2 Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 129. United Biomedical Recent Development
    Table 130. Merck Company Details
    Table 131. Merck Business Overview
    Table 132. Merck β2 Adrenoceptor Agonists Product
    Table 133. Merck Revenue in β2 Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 134. Merck Recent Development
    Table 135. Mylan Company Details
    Table 136. Mylan Business Overview
    Table 137. Mylan β2 Adrenoceptor Agonists Product
    Table 138. Mylan Revenue in β2 Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 139. Mylan Recent Development
    Table 140. Research Programs/Design for This Report
    Table 141. Key Data Information from Secondary Sources
    Table 142. Key Data Information from Primary Sources
List of Figures
    Figure 1. β2 Adrenoceptor Agonists Product Picture
    Figure 2. Global β2 Adrenoceptor Agonists Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global β2 Adrenoceptor Agonists Market Size 2017-2028 (US$ Million)
    Figure 4. United States β2 Adrenoceptor Agonists Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States β2 Adrenoceptor Agonists Market Size 2017-2028 (US$ Million)
    Figure 6. United States β2 Adrenoceptor Agonists Market Share in Global 2017-2028
    Figure 7. β2 Adrenoceptor Agonists Report Years Considered
    Figure 8. Product Picture of Albuterol
    Figure 9. Product Picture of Terbutaline
    Figure 10. Product Picture of Salmeterol
    Figure 11. Product Picture of Formoterol
    Figure 12. Product Picture of Pirbuterol
    Figure 13. Global β2 Adrenoceptor Agonists Market Share by Type in 2022 & 2028
    Figure 14. Global β2 Adrenoceptor Agonists Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. Global β2 Adrenoceptor Agonists Market Share by Type (2017-2028)
    Figure 16. United States β2 Adrenoceptor Agonists Market Share by Type in 2022 & 2028
    Figure 17. United States β2 Adrenoceptor Agonists Market Size by Type (2017-2028) & (US$ Million)
    Figure 18. United States β2 Adrenoceptor Agonists Market Share by Type (2017-2028)
    Figure 19. Product Picture of Bronchial Asthma
    Figure 20. Product Picture of Asthmatic Bronchitis
    Figure 21. Product Picture of Emphysema
    Figure 22. Product Picture of Others
    Figure 23. Global β2 Adrenoceptor Agonists Market Share by Application in 2022 & 2028
    Figure 24. Global β2 Adrenoceptor Agonists Market Size by Application (2017-2028) & (US$ Million)
    Figure 25. Global β2 Adrenoceptor Agonists Market Share by Application (2017-2028)
    Figure 26. United States β2 Adrenoceptor Agonists Market Share by Application in 2022 & 2028
    Figure 27. United States β2 Adrenoceptor Agonists Market Size by Application (2017-2028) & (US$ Million)
    Figure 28. United States β2 Adrenoceptor Agonists Market Share by Application (2017-2028)
    Figure 29. North America β2 Adrenoceptor Agonists Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 30. U.S. β2 Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Canada β2 Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Europe β2 Adrenoceptor Agonists Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 33. Germany β2 Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. France β2 Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. U.K. β2 Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Italy β2 Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Russia β2 Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Asia-Pacific β2 Adrenoceptor Agonists Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 39. China β2 Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Japan β2 Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. South Korea β2 Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. India β2 Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Australia β2 Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Taiwan β2 Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Indonesia β2 Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Thailand β2 Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Malaysia β2 Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Philippines β2 Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Latin America β2 Adrenoceptor Agonists Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Mexico β2 Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Brazil β2 Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Argentina β2 Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Middle East & Africa β2 Adrenoceptor Agonists Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 54. Turkey β2 Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Saudi Arabia β2 Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. U.A.E β2 Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Ivax Pharmaceuticals  Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2017-2022)
    Figure 58. Physicians Total Care Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2017-2022)
    Figure 59. Baxter Healthcare  Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2017-2022)
    Figure 60. Sanofi Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2017-2022)
    Figure 61. Pfizer Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2017-2022)
    Figure 62. Bedford Laboratories Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2017-2022)
    Figure 63. Novartis Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2017-2022)
    Figure 64. Sterimax Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2017-2022)
    Figure 65. Teligent Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2017-2022)
    Figure 66. AstraZeneca Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2017-2022)
    Figure 67. Hikma Pharmaceuticals Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2017-2022)
    Figure 68. Av Kare Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2017-2022)
    Figure 69. Impax Laboratories Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2017-2022)
    Figure 70. PD-Rx Pharmaceuticals Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2017-2022)
    Figure 71. Athenex Pharmaceutical Division Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2017-2022)
    Figure 72. Teva Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2017-2022)
    Figure 73. Marlex Pharmaceuticals Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2017-2022)
    Figure 74. Lannett Company Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2017-2022)
    Figure 75. West-Ward Pharmaceuticals Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2017-2022)
    Figure 76. United Biomedical Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2017-2022)
    Figure 77. Merck Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2017-2022)
    Figure 78. Mylan Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2017-2022)
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed